These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9215865)

  • 1. Expression and intracellular localization of heat shock proteins in multidrug resistance of a cisplatin resistant human ovarian cancer cell line.
    Kamishima T; Fukuda T; Yoshiya N; Suzuki T
    Cancer Lett; 1997 Jun; 116(2):205-11. PubMed ID: 9215865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N; Adachi S; Misawa Y; Yuzawa H; Honda T; Kanazawa K; Takeuchi S Tanaka K; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):7-14. PubMed ID: 2647872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
    Kikuchi Y; Hirata J; Yamamoto K; Ishii K; Kita T; Kudoh K; Tode T; Nagata I; Taniguchi K; Kuwano M
    Jpn J Cancer Res; 1997 Feb; 88(2):213-7. PubMed ID: 9119751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.
    Maubant S; Cruet-Hennequart S; Poulain L; Carreiras F; Sichel F; Luis J; Staedel C; Gauduchon P
    Int J Cancer; 2002 Jan; 97(2):186-94. PubMed ID: 11774263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher induction of heat shock protein 72 by heat stress in cisplatin-resistant than in cisplatin-sensitive cancer cells.
    Abe T; Gotoh S; Higashi K
    Biochim Biophys Acta; 1999 Apr; 1445(1):123-33. PubMed ID: 10209264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.
    Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
    Cancer Lett; 2001 Jul; 168(2):173-81. PubMed ID: 11403922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
    Shridhar V; Bible KC; Staub J; Avula R; Lee YK; Kalli K; Huang H; Hartmann LC; Kaufmann SH; Smith DI
    Cancer Res; 2001 May; 61(10):4258-65. PubMed ID: 11358853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol.
    Shibayama-Imazu T; Sakairi S; Watanabe A; Aiuchi T; Nakajo S; Nakaya K
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):1-11. PubMed ID: 12618894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.
    Sharp SY; Smith V; Hobbs S; Kelland LR
    Br J Cancer; 1998 Jul; 78(2):175-80. PubMed ID: 9683290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
    He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line.
    Kimura E; Enns RE; Thiebaut F; Howell SB
    Cancer Chemother Pharmacol; 1993; 32(4):279-85. PubMed ID: 8100743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
    Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
    J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells.
    Abe T; Gotoh S; Higashi K
    Biochem Pharmacol; 1999 Jul; 58(1):69-76. PubMed ID: 10403520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cisplatin, etoposide and quercetin on Hsp72 expression.
    Jakubowicz-Gil J; Paduch R; Gawron A; Kandefer-Szerszeń M
    Pol J Pathol; 2002; 53(3):133-7. PubMed ID: 12476615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
    Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
    Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins].
    Chen J; Yang R; Liu F
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):617-20. PubMed ID: 11372415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.
    Kimura E; Howell SB
    Cancer Chemother Pharmacol; 1993; 32(6):419-24. PubMed ID: 7903066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.